Literature DB >> 28412900

Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?

Sharon Reif1, Andrea Acevedo1, Deborah W Garnick1, Catherine A Fullerton1.   

Abstract

OBJECTIVE: Individuals with substance use disorders are at high risk of hospital readmission. This study examined whether follow-up services received within 14 days of discharge from an inpatient hospital stay or residential detoxification reduced 90-day readmissions among Medicaid enrollees whose index admission included a substance use disorder diagnosis.
METHODS: Claims data were analyzed for Medicaid enrollees ages 18-64 with a substance use disorder diagnosis coded in any position for an inpatient hospital stay or residential detoxification in 2008 (N=30,439). Follow-up behavioral health services included residential, intensive outpatient, outpatient, and medication-assisted treatment (MAT). Analyses included data from ten states or fewer, based on a minimum number of index admissions and the availability of follow-up services or MAT. Survival analyses with time-varying independent variables were used to test the association of receipt of follow-up services and MAT with behavioral health readmissions.
RESULTS: Two-thirds (67.7%) of these enrollees received no follow-up services within 14 days. Twenty-nine percent were admitted with a primary behavioral health diagnosis within 90 days of discharge. Survival analyses showed that MAT and residential treatment were associated with reduced risk of 90-day behavioral health admission. Receipt of outpatient treatment was associated with increased readmission risk, and, in only one model, receipt of intensive outpatient services was also associated with increased risk.
CONCLUSIONS: Provision of MAT or residential treatment for substance use disorders after an inpatient or detoxification stay may help prevent readmissions. Medicaid programs should be encouraged to reduce barriers to MAT and residential treatment in order to prevent behavioral health admissions.

Entities:  

Keywords:  Admissions & readmissions, addiction, Outpatient treatment, Residential programs, medication-assisted treatment

Mesh:

Year:  2017        PMID: 28412900      PMCID: PMC5895963          DOI: 10.1176/appi.ps.201600339

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  30 in total

Review 1.  Interventions to reduce 30-day rehospitalization: a systematic review.

Authors:  Luke O Hansen; Robert S Young; Keiki Hinami; Alicia Leung; Mark V Williams
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

2.  Medical and surgical readmissions in the Veterans Health Administration: what proportion are related to the index hospitalization?

Authors:  Amy K Rosen; Qi Chen; Marlena H Shin; William O'Brien; Michael Shwartz; Hillary J Mull; Marisa Cevasco; Ann M Borzecki
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

3.  Hospital readmission among medicaid patients with an index hospitalization for mental and/or substance use disorder.

Authors:  Tami L Mark; Tami Mark; Karen Smoyer Tomic; Niranjana Kowlessar; Bong Chul Chu; Rita Vandivort-Warren; Shelagh Smith
Journal:  J Behav Health Serv Res       Date:  2013-04       Impact factor: 1.505

4.  Risk of Early Rehospitalization for Non-Behavioral Health Conditions Among Adult Medicaid Beneficiaries with Severe Mental Illness or Substance Use Disorders.

Authors:  Marion A Becker; Timothy L Boaz; Ross Andel; Samantha Hafner
Journal:  J Behav Health Serv Res       Date:  2017-01       Impact factor: 1.505

5.  Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study.

Authors:  Ian R H Rockett; Sandra L Putnam; Haomiao Jia; Cyril F Chang; Gordon S Smith
Journal:  Ann Emerg Med       Date:  2005-02       Impact factor: 5.721

6.  A performance measure for continuity of care after detoxification: relationship with outcomes.

Authors:  Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds
Journal:  J Subst Abuse Treat       Date:  2014-05-02

7.  Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.

Authors:  Robin E Clark; Mihail Samnaliev; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2009-01       Impact factor: 3.084

8.  Substance use treatment barriers for patients with frequent hospital admissions.

Authors:  Maria C Raven; Emily R Carrier; Joshua Lee; John C Billings; Mollie Marr; Marc N Gourevitch
Journal:  J Subst Abuse Treat       Date:  2009-06-21

Review 9.  Medication-assisted treatment with methadone: assessing the evidence.

Authors:  Catherine Anne Fullerton; Meelee Kim; Cindy Parks Thomas; D Russell Lyman; Leslie B Montejano; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Miriam E Delphin-Rittmon
Journal:  Psychiatr Serv       Date:  2014-02-01       Impact factor: 3.084

Review 10.  Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions.

Authors:  Stacy Sterling; Felicia Chi; Agatha Hinman
Journal:  Alcohol Res Health       Date:  2011
View more
  12 in total

1.  Changes in Residential Substance Use Treatment Service Access Resulting From Recent Medicaid Section 1115 Waivers.

Authors:  Jennifer Miles
Journal:  Psychiatr Serv       Date:  2019-02-13       Impact factor: 3.084

2.  U.S. National 90-Day Readmissions After Opioid Overdose Discharge.

Authors:  Cora Peterson; Yang Liu; Likang Xu; Nisha Nataraj; Kun Zhang; Christina A Mikosz
Journal:  Am J Prev Med       Date:  2019-04-17       Impact factor: 5.043

3.  Substance Use, PTSD Symptoms, and Suicidal Ideation Among Veteran Psychiatry Inpatients: A Latent Class Trajectory Analysis.

Authors:  Noel A Vest; Fernanda S Rossi; Mark Ilgen; Keith Humphreys; Christine Timko
Journal:  J Stud Alcohol Drugs       Date:  2021-11       Impact factor: 2.582

4.  Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.

Authors:  Alexander Y Walley; Sara Lodi; Yijing Li; Dana Bernson; Hermik Babakhanlou-Chase; Thomas Land; Marc R Larochelle
Journal:  Addiction       Date:  2020-02-25       Impact factor: 6.526

Review 5.  Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.

Authors:  Katherine Mackey; Stephanie Veazie; Johanna Anderson; Donald Bourne; Kim Peterson
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

6.  Rural Clients' Continuity Into Follow-Up Substance Use Disorder Treatment: Impacts of Travel Time, Incentives, and Alerts.

Authors:  Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Margaret T Lee; Lee Panas; Grant A Ritter; Kevin Campbell
Journal:  J Rural Health       Date:  2019-05-15       Impact factor: 4.333

Review 7.  Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes.

Authors:  Robert W Kirchoff; Norhan M Mohammed; Jack McHugh; Matej Markota; Thomas Kingsley; Jonathan Leung; M Caroline Burton; Rahul Chaudhary
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-04-08

8.  Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge.

Authors:  Payel J Roy; Ryan Price; Sugy Choi; Zoe M Weinstein; Edward Bernstein; Chinazo O Cunningham; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2021-04-20       Impact factor: 4.852

9.  National trends and characteristics of inpatient detoxification for drug use disorders in the United States.

Authors:  He Zhu; Li-Tzy Wu
Journal:  BMC Public Health       Date:  2018-08-29       Impact factor: 3.295

10.  Factors Associated With Avoidable Emergency Department Visits in Broward County, Florida.

Authors:  Caitlin A Williams; Farzanna Haffizulla
Journal:  Cureus       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.